Insider Transactions in Q1 2021 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
David S Kabakoff Director |
SELL
Open market or private sale
|
Indirect |
30,000
-2.06%
|
$2,010,000
$67.86 P/Share
|
|
Mar 30
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
16,874
-0.51%
|
$995,566
$59.68 P/Share
|
|
Mar 29
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
12,974
-0.95%
|
$765,466
$59.2 P/Share
|
|
Mar 26
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
13,275
-0.48%
|
$796,500
$60.74 P/Share
|
|
Mar 25
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.57%
|
$457,500
$61.18 P/Share
|
|
Mar 24
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.56%
|
$472,500
$63.12 P/Share
|
|
Mar 22
2021
|
David S Kabakoff Director |
SELL
Open market or private sale
|
Indirect |
10,000
-1.34%
|
$670,000
$67.12 P/Share
|
|
Mar 19
2021
|
David S Kabakoff Director |
SELL
Open market or private sale
|
Indirect |
10,000
-1.33%
|
$660,000
$66.17 P/Share
|
|
Mar 18
2021
|
Joseph C. Cook Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,229
+8.95%
|
$195,664
$16.0 P/Share
|
|
Mar 17
2021
|
David S Kabakoff Director |
SELL
Open market or private sale
|
Indirect |
10,000
-1.31%
|
$660,000
$66.14 P/Share
|
|
Mar 16
2021
|
David S Kabakoff Director |
SELL
Open market or private sale
|
Indirect |
120,000
-3.58%
|
$7,560,000
$63.83 P/Share
|
|
Mar 12
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.41%
|
$934,375
$65.22 P/Share
|
|
Mar 11
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.66%
|
$963,125
$67.76 P/Share
|
|
Mar 10
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.49%
|
$920,000
$64.85 P/Share
|
|
Mar 09
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.31%
|
$67,770,000
$9036.17 P/Share
|
|
Mar 08
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.54%
|
$502,500
$67.5 P/Share
|
|
Feb 26
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.32%
|
$1,063,750
$74.23 P/Share
|
|
Feb 25
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.21%
|
$1,121,250
$78.41 P/Share
|
|
Feb 24
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.19%
|
$1,193,125
$83.87 P/Share
|
|
Feb 24
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.23%
|
$622,500
$83.55 P/Share
|
|
Feb 23
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.3%
|
$592,500
$79.11 P/Share
|
|
Feb 10
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.13%
|
$1,394,375
$97.82 P/Share
|
|
Feb 10
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
6,500
-0.19%
|
$624,000
$96.25 P/Share
|
|
Feb 09
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,500
-0.38%
|
$816,000
$96.93 P/Share
|
|
Feb 09
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.3%
|
$1,380,000
$96.05 P/Share
|
|
Feb 08
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.22%
|
$1,365,625
$95.04 P/Share
|
|
Jan 29
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.57%
|
$963,125
$67.35 P/Share
|
|
Jan 28
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,375
-0.42%
|
$977,500
$68.14 P/Share
|
|
Jan 27
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,377
-0.42%
|
$948,882
$66.42 P/Share
|
|
Jan 26
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.39%
|
$547,500
$73.0 P/Share
|
|
Jan 25
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.32%
|
$577,500
$77.87 P/Share
|
|
Jan 15
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,377
-0.41%
|
$1,078,275
$75.68 P/Share
|
|
Jan 14
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,377
-0.4%
|
$1,092,652
$76.15 P/Share
|
|
Jan 13
2021
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct |
14,377
-0.18%
|
$1,049,521
$73.61 P/Share
|
|
Jan 13
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.47%
|
$547,500
$73.29 P/Share
|
|
Jan 12
2021
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
12,113
-0.98%
|
$944,814
$78.28 P/Share
|
|
Jan 12
2021
|
Frank Stokes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-28.27%
|
$585,000
$78.1 P/Share
|
|
Jan 12
2021
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+39.71%
|
$15,000
$2.39 P/Share
|
|
Jan 11
2021
|
Frank Stokes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-25.27%
|
$585,000
$78.26 P/Share
|
|
Jan 11
2021
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+39.71%
|
$15,000
$2.39 P/Share
|